Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial.

BMC Psychiatry
Shinji ShimoderaShimpei Inoue

Abstract

Family psychoeducation is a relatively simple and straightforward intervention whose prophylactic effectiveness and cost-effectiveness is well-established for schizophrenia. We have recently demonstrated its effectiveness for unipolar depression, but its cost-effectiveness has never been examined. We hereby report a cost-effectiveness analysis alongside a randomized controlled trial in order to assess its cost-effectiveness for preventing relapse/recurrence in depression. Fifty-seven patients diagnosed with major depression and undergoing its maintenance treatment, and their primary family members were randomized to treatment as usual (TAU) only or to TAU plus family psychoeducation, which consisted of four 2-hour multiple-family sessions consisting of didactic lectures about depression (30 minutes) and group discussion and problem solving (60-90 minutes). The economic analyses were undertaken from the perspective of the National Health Insurance (NHI), assuming the most reasonable price of US$50 per psychoeducation session per patient. The main outcome measures included relapse-free days and direct costs to the NHI. The intervention group enjoyed 272 (SD: 7.1) relapse-free days, while the control group spent 214 (SD: 90.8) rel...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Apr 28, 2000·BMJ : British Medical Journal·S G Thompson, J A Barber
Dec 16, 2000·The British Journal of Psychiatry : the Journal of Mental Science·T A FurukawaK Takahashi
Jul 25, 2003·Psychological Medicine·T KanaiK Takahashi
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Jan 20, 2004·The Journal of Clinical Psychiatry·Paul E GreenbergPatricia K Corey-Lisle
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Koen DemyttenaereUNKNOWN WHO World Mental Health Survey Consortium
Jul 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Paul McCroneAndre Tylee
Aug 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Elisabeth Fenwick, Sarah Byford
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Oct 21, 2006·The Cochrane Database of Systematic Reviews·F PharoahW Wong
May 15, 2007·Medical Care·Jeffrey M PyneJohn Fortney
Jan 18, 2008·The New England Journal of Medicine·Erick H TurnerRobert Rosenthal
Dec 15, 2010·Schizophrenia Bulletin·Jun XiaMadhvi R Belgamwar
Feb 24, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Kae ShimazuShimpei Inoue
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Jun XiaMadhvi R Belgamwar
Aug 20, 2011·Psychiatry and Clinical Neurosciences·Mitsuhiro SadoTakehiko Kikkawa

❮ Previous
Next ❯

Citations

Jul 15, 2015·The International Journal of Neuropsychopharmacology·Kang SimRoss J Baldessarini
Sep 14, 2014·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·Tomasz ZaprutkoAndrzej Pogłodziński
Aug 4, 2020·The Journal of Nutrition, Health & Aging·M ChamparnaudF Nourhashémi
Jan 23, 2016·International Journal of Geriatric Psychiatry·Sarah T StahlMary Amanda Dew
Nov 20, 2016·Journal of Marital and Family Therapy·Pamela BradyKatherine McGill
Apr 23, 2021·The Cochrane Database of Systematic Reviews·Ellen Van LeeuwenThierry Christiaens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.